Key Highlights

  • Clean Energy Technologies (NASDAQ:CETY): up 13.64% to USD 1.00, with a USD 500,000 convertible note disclosed.
  • iOThree (NASDAQ:IOTR): down 8.21% to USD 1.90, after a September 2026 unit offering filing.
  • Niki BioSolutions (NASDAQ:NIKI): down 8.28% to USD 1.55, with a USD 75 million shelf filed.
  • SurgePays (NASDAQ:SURG): up 8.57% to USD 0.1672, with cash of USD 1,954,235.
  • TEN Holdings (NASDAQ:XHLD): up 9.24% to USD 0.89, with a USD 100 million shelf filed.
  • Cellyan Biotechnology (NASDAQ:HKPD): up 9.29% to USD 2.00, with a USD 200 million shelf filed.

Clean Energy Technologies (NASDAQ:CETY) (up USD 0.1200, 13.64%): Convertible Note in the Background

Clean Energy Technologies (NASDAQ:CETY) was up 13.64% to USD 1.00 in pre-market trading on November 3, 2026. No announcement dated October 30 to November 3, 2026 was identified, so the move has no confirmed catalyst. This is a penny stock, so Volatility and dilution risk are elevated.

On October 21, 2026 the company disclosed an 8% convertible note of USD 500,000, converting at 85% of the lowest traded price over the prior 10 trading days. It also disclosed a May 26, 2026 Nasdaq notice over an unfiled quarterly report, and whether the filing has since been made was not confirmed.

iOThree (NASDAQ:IOTR) (down USD 0.1699, 8.21%): Unit Offering Filing Looms

iOThree (NASDAQ:IOTR) was down 8.21% to USD 1.90 in pre-market trading on November 3, 2026. No company announcement dated November 2 or November 3, 2026 was identified, and the move may reflect thin trading.

The company filed in September 2026 to offer about 1.99 million units on a best efforts basis, and any completed offering could dilute current holders. Trailing twelve month Revenue was about USD 14.71 million with a net loss of about USD 1.16 million, and the Market Value was about USD 9.83 million as of October 21, 2026.

Niki BioSolutions (NASDAQ:NIKI) (down USD 0.1399, 8.28%): Shelf Filed After a Merger

Niki BioSolutions (NASDAQ:NIKI) was down 8.28% to USD 1.55 in pre-market trading on November 3, 2026. No announcement dated November 2 or November 3, 2026 was identified. Its most recent news was an October 14, 2026 Partnership for plasma based APOE genotyping.

The company filed a USD 75 million mixed securities shelf in early September 2026, which could dilute holders if used. Market value was about USD 5.97 million as of October 21, 2026, and the 52 week range of USD 0.60 to USD 12.24 shows how wide swings have been.

SurgePays (NASDAQ:SURG) (up USD 0.0132, 8.57%): Thin Cash Against Rising Revenue

SurgePays (NASDAQ:SURG) was up 8.57% to USD 0.1672 in pre-market trading on November 3, 2026. No announcement dated October 30 to November 3, 2026 was identified, so the gain may reflect trading activity in a penny stock.

Second quarter 2026 revenue was USD 16.20 million, up 40.7%. Cash and cash equivalents were USD 1,954,235 at June 30, 2026, a thin cushion that makes funding needs and potential share issuance relevant. The reported profit also included an USD 8.51 million gain on contract settlement.

TEN Holdings (NASDAQ:XHLD) (up USD 0.0753, 9.24%): Shelf and a Delayed Vote

TEN Holdings (NASDAQ:XHLD) was up 9.24% to USD 0.89 in pre-market trading on November 3, 2026. The annual meeting was adjourned on October 29, 2026 and will reconvene on November 12, 2026, but no announcement dated October 30 to November 3, 2026 was identified.

A registration statement for a USD 100 million mixed securities shelf was filed on October 16, 2026, against a market value of roughly USD 10 million. Market data showed a trailing net loss of USD 17.78 million, and the chief financial officer agreed to step down on September 30, 2026.

Cellyan Biotechnology (NASDAQ:HKPD) (up USD 0.1700, 9.29%): Reverse Split and a Shelf

Cellyan Biotechnology (NASDAQ:HKPD) was up 9.29% to USD 2.00 in pre-market trading on November 3, 2026. A 1-for-20 Reverse Stock Split took effect on October 26, 2026, and no announcement dated October 30 to November 3, 2026 was identified.

The company filed a shelf registration for up to USD 200 million on June 12, 2026, which could lead to dilution if used. Nasdaq set a January 11, 2027 deadline to regain a closing bid of at least USD 1.00 for ten consecutive Business days.

Where Things Stand

Each of the six companies has a filing, note or shelf that leaves room for new shares, and five of the six moves had no identified catalyst. Watch for any use of the shelves, completion of the iOThree unit offering, conversions under the Clean Energy Technologies note, Nasdaq notices, and whether pre-market moves hold once regular trading opens.